Skip to main content

Advertisement

Log in

Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To explore the role of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), using semiquantitative and quantitative parameters, and diffusion-weighted (DW) MRI in differentiating benign from malignant small, non-palpable solid testicular tumours.

Methods

We calculated the following DCE-MRI parameters of 47 small, non-palpable solid testicular tumours: peak enhancement (PE), time to peak (TTP), percentage of peak enhancement (Epeak), wash-in-rate (WIR), signal enhancement ratio (SER), volume transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve) and initial area under the curve (iAUC). DWI signal intensity and apparent diffusion coefficient (ADC) values were evaluated.

Results

Epeak, WIR, Ktrans , Kep and iAUC were higher and TTP shorter in benign compared to malignant lesions (p < 0.05). All tumours had similar ADC values (p > 0.07). Subgroup analysis limited to the most frequent histologies – Leydig cell tumours (LCTs) and seminomas – replicated the findings of the entire set. Best diagnostic cutoff value for identification of seminomas: Ktrans ≤0.135 min−1, Kep ≤0.45 min−1, iAUC ≤10.96, WIR ≤1.11, Epeak ≤96.72, TTP >99 s.

Conclusions

DCE-MRI parameters are valuable in differentiating between benign and malignant small, non-palpable testicular tumours, especially when characterising LCTs and seminomas.

Key Points

DCE-MRI may be used to differentiate benign from malignant non-palpable testicular tumours.

Seminomas show lower Ktrans, Kep and iAUC values.

ADC values are not valuable in differentiating seminomas from LCTs.

Semiquantitative DCE-MRI may be used to characterise small, solid testicular tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

AIF:

Arterial input function

DCE:

Dynamic contrast-enhanced

DW:

Diffusion-weighted

EG-VEGF:

Endocrine-gland vascular endothelial growth factor

Epeak:

Percentage of peak enhancement

EPI:

Single-shot spin-echo echo-planar imaging

FA:

Flip angle

Flash:

Fast low-angle single shot Gradient-Echo

FOV:

Field of view

GRE:

Gradient echo

HASTE:

Half-Fourier-Acquired Single-shot Turbo spin Echo

iAUC:

Initial area under curve

IVIM:

Intravoxel incoherent motion

Kep :

Rate constant

Ktrans :

Volume transfer constant

LCTs:

Leydig cell tumours

MRI:

Magnetic resonance imaging

PE:

Peak enhancement

ROIs:

Regions of interests

S0 :

Signal intensity on the dynamic precontrast image

S1 :

Signal intensity on the first dynamic post-contrast image

SER:

Signal enhancement ratio

Sf :

Signal intensity at the last contrast-enhancement point

Si:

Signal intensities

SL:

Slice thickness

Speak :

Signal intensity at the moment of the peak enhancement

T:

Tesla

T1-W:

T1-weighted

T2-W:

T2-weighted

TE:

Echo time

TIC:

Time-intensity curve

TR:

Repetition time

TSE:

Turbo spin echo

TTP:

Time to peak

US:

Ultrasound

Ve :

Extravascular extracellular space volume fraction

VEGF:

Vascular endothelial growth factor

VIBE:

Volumetric interpolated breath-hold examination

WIR:

Wash-in-rate

References

  1. Barrisford GW, Kreydin EI, Preston MA, Rodriguez D, Harisighani MG, Feldman AS (2015) Role of imaging in testicular cancer: current and future practice. Future Oncol 11:2575–2586

    Article  CAS  PubMed  Google Scholar 

  2. Marko J, Wolfman DJ, Aubin AL, Sesterhenn IA (2017) Testicular Seminoma and Its Mimics. Radiographics 2:160164

    Google Scholar 

  3. Verrill C, Yilmaz A, Srigley JR (2017) Urological Pathology Testicular Tumor Panel. Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations. Am J Surg Pathol 41:e22–e32

    Article  PubMed  Google Scholar 

  4. Hayes-Lattin B, Nichols CR (2009) Testicular cancer: a prototypic tumor of young adults. Semin Oncol 36:432–438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Stokes W, Amini A, Maroni PD (2017) Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol S1477-5131:30009–30008

    Google Scholar 

  6. Rocher L, Ramchandani P, Belfield J et al (2016) Incidentally detected non-palpable testicular tumours in adults at scrotal ultrasound: impact of radiological findings on management Radiologic review and recommendations of the ESUR scrotal imaging subcommittee. Eur Radiol 26:2268–2278

    Article  PubMed  Google Scholar 

  7. Dieckmann K-P, Frey U, Lock G et al (2013) Contemporary diagnostic work-up of testicular germ cell tumours. Nat Rev Urol 10:703–712

    Article  PubMed  Google Scholar 

  8. Nicolai N, Necchi A, Raggi D et al (2015) Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease. Urology 85:402–406

    Article  PubMed  Google Scholar 

  9. Brunocilla E, Gentile G, Schiavina R et al (2013) Testis-sparing Surgery for the Conservative Management of Small Testicular Masses: An Update. Anticancer Res 33:5205–5210

    PubMed  Google Scholar 

  10. Sharman R (2017) European Association of Urology - 32nd Annual Congress (March 24-28, 2017 - London, UK). Drugs Today (Barc) 53:257–263. doi:https://doi.org/10.1358/dot.2017.53.4.2630607

  11. Albers P, Albrecht W, Algaba F, European Association of Urology et al (2015) Guidelines on Testicular Cancer: 2015 Update. Eur Urol 68:1054–1068

    Article  PubMed  Google Scholar 

  12. Isidori AM, Pozza C, Gianfrilli D et al (2014) Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors. Radiology 273:606–618

    Article  PubMed  Google Scholar 

  13. Pozza C, Gianfrilli D, Fattorini G et al (2016) Diagnostic value of qualitative and strain ratio elastography in the differential diagnosis of non-palpable testicular lesions. Andrology 4:1193–1203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Drudi FM, Valentino M, Bertolotto M et al (2015) CEUS Time Intensity Curves in the Differentiation Between Leydig Cell Carcinoma and Seminoma: A Multicenter Study. Ultraschall Med 37:201–205

    Article  PubMed  Google Scholar 

  15. Sohaib SA, Koh DM, Husband JE et al (2008) The role of imaging in the diagnosis, staging, and management of testicular cancer. Am J Roentgenol 191:387–395

    Article  Google Scholar 

  16. Coursey Moreno C, Small WC, Camacho JC et al (2015) Testicular tumors: what radiologists need to know--differential diagnosis, staging, and management. Radiographics 35(2):400–415

    Article  PubMed  Google Scholar 

  17. Tsili AC, Tsampoulas C, Giannakopoulos X et al (2007) MRI in the histologic characterization of testicular neoplasms. AJR Am J Roentgenol 189:W331–W337

    Article  PubMed  Google Scholar 

  18. Mohrs OK, Thoms H, Egner T (2012) MRI of Patients With Suspected Scrotal or Testicular Lesions: Diagnostic Value in Daily Practice. AJR Am J Roentgenol 199:609–615

    Article  PubMed  Google Scholar 

  19. Woldrich JM, Im RD, Hughes-Cassidy FM, Aganovic L, Sakamoto K (2013) Magnetic resonance imaging for intratesticular and extratesticular scrotal lesions. Can J Urol 20:6855–6859

    PubMed  Google Scholar 

  20. Tsili AC, Argyropoulou MI, Astrakas LG (2013) Dynamic contrast-enhanced subtraction MRI for characterizing intratesticular mass lesions. AJR Am J Roentgenol 200:578–585

    Article  PubMed  Google Scholar 

  21. Tsili AC, Argyropoulou MI, Giannakis D, Sofikitis N, Tsampoulas K (2010) MRI in the characterization and local staging of testicular neoplasms. AJR Am J Roentgenol 194:682–689

    Article  PubMed  Google Scholar 

  22. Manganaro L, Vinci V, Pozza C (2015) A prospective study on contrast-enhanced magnetic resonance imaging of testicular lesions: distinctive features of Leydig cell tumours. Eur Radiol 25:3586–3595

    Article  PubMed  Google Scholar 

  23. Sanharawi IE, Correas JM, Glas L (2016) Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI. Eur J Radiol 85:2072–2082

    Article  PubMed  Google Scholar 

  24. Port RE, Bernstein LJ, Barboriak DP, Xu L, Roberts TPL, van Bruggen N (2010) Non compartmental Kinetic analysis of DCE-RMI data from malignant tumors: appluication to Glioblastoma Treated with bevacizumab. Magn Reson Med 64:408–417

    CAS  PubMed  Google Scholar 

  25. Chen BB, Hsu CY, Yu CW et al (2016) Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy. Radiology 281:983

    Article  PubMed  Google Scholar 

  26. Leach MO, Morgan B, Tofts PS (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22:1451–1464

    Article  CAS  PubMed  Google Scholar 

  27. Ma L, Xu X, Zhang M et al (2016) Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis. Magn Reson Imaging 37:27–32

    Article  CAS  PubMed  Google Scholar 

  28. Ryu JK, Rhee SJ, Song JY, Cho SH, Jahng GH (2016) Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer. J Appl Clin Med Phys 17:6091

    Article  Google Scholar 

  29. Gaddikeri S, Hippe DS, Anzai Y et al (2016) Dynamic Contrast-Enhanced MRI in the Evaluation of Carotid Space Paraganglioma versus Schwannoma. J Neuroimaging 26:618–625

    Article  PubMed  Google Scholar 

  30. Zhang W, Kong X, Wang ZJ, Luo S, Huang W, Zhang LJ (2015) Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. PLoS One 10:e0129621

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bakir B, Yilmaz F, Turkay R et al (2014) Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology 272:438–445

    Article  PubMed  Google Scholar 

  32. Tsili AC, Sylakos A, Ntorkou A et al (2015) Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from nonseminomatous testicular neoplasms. Eur J Radiol 84:1219–1226

    Article  PubMed  Google Scholar 

  33. Tsili AC, Ntorkou A, Baltogiannis D et al (2015) The role of apparent diffusion coefficient values in detecting testicular intraepithelial neoplasia: preliminary results. Eur J Radiol 84:828–833

    Article  PubMed  Google Scholar 

  34. An YY, Kim SH, Kang BJ (2017) Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T. PLoS ONE 12:e0174681

    Article  PubMed  PubMed Central  Google Scholar 

  35. Luo Z, Litao L, Gu S et al (2016) Standard-b-value vs low-b-value DWI for differentiation of benign and malignant vertebral fractures: a meta-analysis. Br J Radiol 89:20150384

    Article  PubMed  PubMed Central  Google Scholar 

  36. Jeon JY, Chung HW, Lee MH et al (2016) Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions. Br J Radiol 89:20150929

    Article  PubMed  PubMed Central  Google Scholar 

  37. Tang YZ, Benardin L, Booth TC et al (2014) Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses. Br J Radiol 87:20130730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Tsili AC, Ntorkou A, Astrakas L et al (2017) Diffusion-weighted magnetic resonance imaging in the characterization of testicular germ cell neoplasms: Effect of ROI methods on apparent diffusion coefficient values and interobserver variability. Eur J Radiol 89:1–6

    Article  PubMed  Google Scholar 

  39. Tsili AC, Argyropoulou MI, Giannakis D, Tsampalas S, Sofikitis N, Tsampoulas K (2012) Diffusion-weighted MR imaging of normal and abnormal scrotum: preliminary results. Asian J Androl 14:649–654

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sonmez G, Sivrioglu AK, Velioglu M et al (2012) Optimized imaging techniques for testicular masses: fast and with high accuracy. Wien Klin Wochenschr 124:704–708. doi:https://doi.org/10.1007/s00508-012-0233-y

  41. Kim JY, Kim SH, Kim YJ (2015) Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers? Magn Reson Imaging 33:72–80. doi:https://doi.org/10.1016/j.mri.2014.08.034

  42. Sanz-Requena R, Martí-Bonmatí L, Pérez-Martínez R, García-Martí G (2016) Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness. Eur J Radiol 85:2119–2126

    Article  PubMed  Google Scholar 

  43. Tofts PS, Wicks DA, Barker GJ (1991) The MRI measurement of NMR and physiological parameters in tissue to study disease process. Prog Clin Biol Res 363:313–325

    CAS  PubMed  Google Scholar 

  44. Jansen SA, Shimauchi A, Zak L (2009) Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol 193:832–839

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kazerooni AF, Malek M, Haghighatkhah H et al (2016) Semiquantitative dynamic contrast-enhanced MRI for accurate classification of complex adnexal masses. J Magn Reson Imaging 45:418–427

    Article  PubMed  Google Scholar 

  46. Li KL, Partridge SC, Joe BN et al (2008) Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology 248:79–87

    Article  PubMed  PubMed Central  Google Scholar 

  47. Esserman L, Hylton N, George T, Weidner N (1999) Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5:13–21

    Article  PubMed  Google Scholar 

  48. Maki D, Watanabe Y, Nagayama M et al (2011) Diffusion-weighted magnetic resonance imaging in the detection of testicular torsion: feasibility study. J Magn Reson Imaging 34:1137–1142

    Article  PubMed  Google Scholar 

  49. Watanabe Y, Nagayama M, Okumura A et al (2007) MR imaging of testicular torsion: features of testicular hemorrhagic necrosis and clinical outcomes. J Magn Reson Imaging 26:100–108

    Article  PubMed  Google Scholar 

  50. Kantarci M, Doganay S, Yalcin A, Aksoy Y, Yilmaz-Cankaya B, Salman B (2010) Diagnostic performance of diffusion-weighted MRI in the detection of nonpalpable undescended testes: comparison with conventional MRI and surgical findings. AJR Am J Roentgenol 195:W268–W273

    Article  PubMed  Google Scholar 

  51. Watanabe Y, Dohke M, Ohkubo K et al (2000) Scrotal disorders: evaluation of testicular enhancement patterns at dynamic contrast-enhanced subtraction MR imaging. Radiology 217:219–227

    Article  CAS  PubMed  Google Scholar 

  52. Samson M, Peale FV Jr, Frantz G et al (2004) Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89:4078–4088

    Article  CAS  PubMed  Google Scholar 

  53. Fernández GC, Tardáguila F, Rivas C et al (2004) MRI in the diagnosis of testicular Leydig cell tumour. Br J Radiol 77:521–524

    Article  PubMed  Google Scholar 

  54. Siemann DW (2011). Tumor microenvironment. Wiley-Blackwell

  55. Algebally AM, Tantawy HI, Yousef RR, Szmigielski W, Darweesh A (2015) Advantage of Adding Diffusion Weighted Imaging to Routine MRI Examinations in the Diagnostics of Scrotal Lesions. Pol J Radiol 80:442–449

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matteo Saldari.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Lucia Manganaro.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Funding

The authors state that this work has not received any funding.

Statistics and biometry

Carlotta Pozza has significant statistical expertise.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• prospective

• observational

• performed at one institution

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manganaro, L., Saldari, M., Pozza, C. et al. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours. Eur Radiol 28, 554–564 (2018). https://doi.org/10.1007/s00330-017-5013-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-017-5013-7

Keywords

Navigation